‘Magic Leap’ may help people with color blindness be treated through augmented reality

South Florida technology developer Magic Leap has filed a patent application describing a wearable device that uses augmented reality to treat color blindness.

Magic Leap is combining that inherent visual ability with mobile computing – giving you visual output equivalent to when you step outside into the world, but powered by the mobile tech you carry around. Using Dynamic Digitized Lightfield Signal™, imagine being able to generate images indistinguishable from real objects and then being able to place those images seamlessly into the real world. We are visionaries, rocket scientists, artificial intelligence gurus, robotics wizards, visualization jedis, software ninjas, computing hobbits, film freaks, mathematical artists, psychedelic physicists, people people, business athletes, and music lovers. We are creating a whole new user experience that we call Cinematic Reality.

This overlap of red and green light is what the EnChroma glasses correct.

Magic Leap is a proprietary wearable technology that enables users to interact with digital devices in a completely visually cinematic way.

Color blindness is caused by a problem with the cones in your eyes that discriminate color. Instead of differentiating the wavelengths of light as specific colors, the cones register them as all about the same. It’s like what happens when you mix too many colors of paint together and just make brown every time — but instead, the cones in your eyes are doing this to specific colors of light.

  • The device comprises an augmented reality head-mounted ophthalmic system that features a wearable augmented reality display platform.
  • The system is configured to pass light from the world into an eye of a wearer and modify the light on a colour detection deficiency of the wearer.
  • Specifically, the device’s sensors calculate what colours a person cannot see and then amplify the wavelengths of light so it can apply a filter so none of the colours overlap.
  • Additionally, the patent reportedly mentions diagnosing eye conditions, such as  myopia, hyperopia and astigmatism.

Leave a Reply

Your email address will not be published. Required fields are marked *